Replies to post #14351 on Aethlon Medical Inc (AEMD)

[hopester]

1/50 was unnecessary and any R/S should come AFTER ( not before) they prove their product by approvals, and orders.
Why not 1/25 after they can get the sh px to say $.50 with solid organic news?

What's the point of having only 6.7mil share out there except to permit ongoing issuance of same to finance their work.

The motives behind this drastic reversal beyond the listing and institutional interest this may invite , is suspect to me.

Small investors need clarification, answers and RESULTS.